Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound

International Journal of Infectious Diseases - Tập 8 Số 4 - Trang 223-226 - 2004
Els Keyaerts1, Leen Vijgen1, Luni Chen2,3, Piet Maes1, Göran Hedenstierna2, Marc Van Ranst1
1Laboratory of Clinical and Epidemiological Virology, Department of Microbiology & Immunology, Rega Institute for Medical Research, University of Leuven, Minderbroedersstraat 10, BE-3000 Leuven, Belgium
2Department of Medical Sciences, Clinical Physiology, Uppsala University, Sweden
3General Airforce Hospital of China, Beijing, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Drosten, 2003, Identification of a novel coronavirus in patients with severe acute respiratory syndrome, N Engl J Med, 348, 1967, 10.1056/NEJMoa030747

Zhaori, 2003, Antiviral treatment of SARS: can we draw any conclusions?, CMAJ, 169, 1165

Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658

Lane, 1997, Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus, J Virol, 71, 2202, 10.1128/JVI.71.3.2202-2210.1997

Cinatl, 2003, Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus, Lancet, 361, 2045, 10.1016/S0140-6736(03)13615-X

Jeong, 2002, Induction of inducible nitric oxide synthase expression by 18β-glycyrrherinic acid in macrophages, FEBS Lett, 513, 208, 10.1016/S0014-5793(02)02311-6

Ignarro, 1981, Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates, Pharmacol Exp Ther, 218, 739

Pauwels, 1988, Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds, J Virol Methods, 20, 309, 10.1016/0166-0934(88)90134-6

Goodwin, 1995, Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS, J Immunol Methods, 179, 95, 10.1016/0022-1759(94)00277-4

Bates, 1991, Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required, Biochem Pharmacol, 42, 157, 10.1016/0006-2952(91)90406-U

Marks, 1991, Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 × g supernatant: biotransformation and nitric oxide formation, Can J Physiol Pharmacol, 69, 889, 10.1139/y91-135

Kowaluk, 1992, Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle, J Pharmacol Exp Ther, 262, 916

Megson, 2000, Nitric oxide donor drugs, Drugs of the Future, 25, 701, 10.1358/dof.2000.025.07.858691